Appendix S2. Explanation of pharmacophore feature abbreviations

Arginine -1
Positive: a pharmacophore feature representing positive charge is placed on Arginine -1.
Cysteine 2
HB->D (backbone): A pharmacophore feature representing the hydrogen bond donor capability of the backbone of Cysteine 2.
Valine 3
Hydro: A pharmacophore feature representing the hydrophobic characteristic of Valine 3.
Tryptophan 4
Arom (2): Both the six and five-member rings are defined as aromatic features. Hydro (2): Both the six and five-member rings are defined as hydrophobic features. Arom: Only the six-member ring is defined as an aromatic feature. Hydro: Only the six-member ring is defined as a hydrophobic feature. Arom+Hydro: The six-member ring defined as an aromatic feature and the five-member ring as a hydrophobic feature. Arom+ HB->D (NE1): The six-member ring defined as an aromatic feature and the five-member ring has a hydrogen bond donor feature at NE1. Hydro+ HB->D (NE1): The six-member ring defined as a hydrophobic feature and the fivemember ring has a hydrogen bond donor feature at NE1.
Glutamine 5
HB<-A (OE1): A hydrogen bond acceptor feature at OE1 of Glutamine 5.
Aspartic Acid 6
HB->D (backbone): A pharmacophore feature representing the hydrogen bond donor capability of the backbone of Aspartic Acid 6. HB<-A (OD1 or OD2): A pharmacophore feature representing the hydrogen bond acceptor capabilities of OD1 or OD2 on Aspartic Acid 6.
Tryptophan 7
Arom (2): Both the six and five-member rings are defined as aromatic features. Hydro (2): Both the six and five-member rings are defined as hydrophobic features. Arom: Only the six-member ring is defined as an aromatic feature. Hydro: Only the six-member ring is defined as a hydrophobic feature. Arom+Hydro: The six-member ring defined as an aromatic feature and the five-member ring as a hydrophobic feature. Arom+ HB->D (NE1): The six-member ring defined as an aromatic feature and the five-member ring has a hydrogen bond donor feature at NE1. Hydro+ HB->D (NE1): The six-member ring defined as a hydrophobic feature and the fivemember ring has a hydrogen bond donor feature at NE1. 
HB->D (backbone)
:
Appendix S3. Intermolecular interaction analysis
The binding site on C3 can be divided into 4 sectors based on residues in direct contact with compstatin (I: 344-349, II: 388-393, III: 454-462, and IV: 488-492) [1] [2] [3] . From analysis of the MD trajectory of C3c-bound compstatin analog with sequence Ac-RSI[CVWQDWGAHRC]T-NH2, we identified persistent intermolecular interactions that confirm these contacts (Table 1) . Occupancy analysis of hydrogen bonds in the MD trajectory demonstrate persistent (>60% occupancy) between compstatin and C3c. R-1, C2, W4, Q5, W7, A9, and H10 are some of the residues participating in these conserved hydrogen bonds that are also consistent with prior experimental data. Residues R-1 and D6 were identified as contributors to highly conserved salt bridges as well. These intermolecular interactions, corroborated by previous energetic analysis 4 , subsequently informed the choice of pharmacophore features and generation of the models. Table S1 -Electrostatic analysis of the MD trajectory of C3c:RSI-compstatin a .
Hydrogen Bonds
R459-CZ a Hydrogen bonds and ionic interactions are those with at least 60% occupancy in the trajectory. A hydrogen bond is identified according to Baker-Hubbard criteria as implemented in MDTraj. An ionic interaction is identified using a range of up to 8 Å. Figure S1 -Two-dimensional structures of experimentally tested chemical compounds
